IBRO neuroscience reports · 2026
Exercise attenuates neuropathic pain and neuroinflammation in an obese rat model exhibiting diabetes-related metabolic dysfunction and features of type 2 diabetes.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sumizono Megumi, Kakimoto Shogo, Nakanishi Kazuki, Matsuzaki Ryoma, Kato Yuki, Yoshizato Yushin, Imai Takaki, Sakakima Harutoshi
Аннотация
This study aimed to investigate the effects and mechanisms of exercise intervention on neuropathic pain in an obese rat model exhibiting diabetes-related metabolic dysfunction. Chronic constriction injury (CCI) was induced in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, and the animals were randomly assigned to three groups: exercise (Ex), no-exercise (No-Ex), and normal controls. The 50% pain response threshold was significantly higher in the Ex group than in the No-Ex group 5 weeks post-CCI (p < 0.05). Monocyte chemoattractant protein-1(MCP-1), C-C chemokine receptor 2 (CCR2), P2X purinoceptor 4 (P2X4R), and tumor necrosis factor receptor-associated factor 6(TRAF6) which are related to microglia in the dorsal horn of the spinal cord, were significantly decreased in the Ex group compared to the No-Ex group (p < 0.05). In the hippocampal dentate gyrus, tumor necrosis factor-α(TNF-α) and interleukin 6(IL-6) were significantly decreased in the Ex group compared with the No-Ex group (p < 0.05). However, no significant differences were observed in doublecortin expression, the Y-maze, or the alternation rate in the passive avoidance test (p > 0.05). In neuropathic pain in diabetes, targets of interest include not only P2X4R but also CCR2 and TRAF6. Furthermore, the synergistic effects of chronic pain and neuroinflammation, such as neuropathic pain with a diabetic background, may accelerate the progression of dysfunction in memory-related regions and require continued validation.